PortfoliosLab logoPortfoliosLab logo
FTNT vs. UTHR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FTNT vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fortinet, Inc. (FTNT) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTNT achieves a 84.23% return, which is significantly higher than UTHR's 12.05% return. Over the past 10 years, FTNT has outperformed UTHR with an annualized return of 36.02%, while UTHR has yielded a comparatively lower 17.67% annualized return.


FTNT

1D
0.85%
1M
24.31%
YTD
84.23%
6M
77.94%
1Y
43.91%
3Y*
27.56%
5Y*
26.15%
10Y*
36.02%

UTHR

1D
0.10%
1M
-5.79%
YTD
12.05%
6M
10.52%
1Y
90.80%
3Y*
33.49%
5Y*
24.97%
10Y*
17.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FTNT vs. UTHR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FTNT
Fortinet, Inc.
84.23%-15.95%61.42%19.72%-31.98%141.97%39.13%51.58%61.20%45.05%
UTHR
United Therapeutics Corporation
12.05%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%

Correlation

The correlation between FTNT and UTHR is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.04

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Nov 18, 2009

0.24

The correlation between FTNT and UTHR shifts across timeframes, from -0.05 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FTNT:

$108.67B

UTHR:

$25.77B

EPS

FTNT:

$2.58

UTHR:

$27.00

PE Ratio

FTNT:

56.81

UTHR:

20.22

PEG Ratio

FTNT:

1.58

UTHR:

0.66

PS Ratio

FTNT:

15.62

UTHR:

8.21

PB Ratio

FTNT:

109.80

UTHR:

4.37

Total Revenue (TTM)

FTNT:

$7.11B

UTHR:

$3.17B

Gross Profit (TTM)

FTNT:

$5.74B

UTHR:

$2.74B

EBITDA (TTM)

FTNT:

$2.47B

UTHR:

$1.75B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTNT vs. UTHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTNT
FTNT Risk / Return Rank: 6969
Overall Rank
FTNT Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
FTNT Sortino Ratio Rank: 6767
Sortino Ratio Rank
FTNT Omega Ratio Rank: 7373
Omega Ratio Rank
FTNT Calmar Ratio Rank: 7070
Calmar Ratio Rank
FTNT Martin Ratio Rank: 6363
Martin Ratio Rank

UTHR
UTHR Risk / Return Rank: 9494
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTNT vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fortinet, Inc. (FTNT) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FTNTUTHRDifference
Sharpe ratioReturn per unit of total volatility

-0.95

Sortino ratioReturn per unit of downside risk

-2.76

Omega ratioGain probability vs. loss probability

1.23

1.49

-0.26

Calmar ratioReturn relative to maximum drawdown

1.43

8.58

-7.15

Martin ratioReturn relative to average drawdown

2.09

20.13

-18.04

FTNT vs. UTHR - Sharpe Ratio Comparison

The current FTNT Sharpe Ratio is 0.98, which is lower than the UTHR Sharpe Ratio of 1.92. The chart below compares the historical Sharpe Ratios of FTNT and UTHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FTNT vs. UTHR - Drawdown Comparison

The maximum FTNT drawdown since its inception was -51.20%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for FTNT and UTHR.


Loading charts...

Drawdown Indicators


FTNTUTHRDifference

Max Drawdown

Largest peak-to-trough decline

-51.20%

-93.18%

+41.98%

Max Drawdown (1Y)

Largest decline over 1 year

-30.90%

-10.64%

-20.26%

Max Drawdown (3Y)

Largest decline over 3 years

-38.32%

-33.00%

-5.32%

Max Drawdown (5Y)

Largest decline over 5 years

-38.32%

-33.00%

-5.32%

Max Drawdown (10Y)

Largest decline over 10 years

-38.32%

-55.56%

+17.24%

Current Drawdown

Current decline from peak

-2.25%

-8.51%

+6.26%

Average Drawdown

Average peak-to-trough decline

-16.22%

-35.31%

+19.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.07%

4.53%

+16.54%

Volatility

FTNT vs. UTHR - Volatility Comparison

Fortinet, Inc. (FTNT) has a higher volatility of 13.35% compared to United Therapeutics Corporation (UTHR) at 5.01%. This indicates that FTNT's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTNTUTHRDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.35%

5.01%

+8.34%

Volatility (6M)

Calculated over the trailing 6-month period

31.79%

25.94%

+5.85%

Volatility (1Y)

Calculated over the trailing 1-year period

45.18%

47.55%

-2.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.94%

35.08%

+8.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.88%

35.06%

+5.82%

Dividends

FTNT vs. UTHR - Dividend Comparison

Neither FTNT nor UTHR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FTNT vs. UTHR - Financials Comparison

This section allows you to compare key financial metrics between Fortinet, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B20222023202420252026
1.85B
781.50M
(FTNT) Total Revenue
(UTHR) Total Revenue
Values in USD except per share items

FTNT vs. UTHR - Profitability Comparison

The chart below illustrates the profitability comparison between Fortinet, Inc. and United Therapeutics Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

75.0%80.0%85.0%90.0%95.0%20222023202420252026
80.3%
82.9%
Portfolio components
FTNT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fortinet, Inc. reported a gross profit of 1.49B and revenue of 1.85B. Therefore, the gross margin over that period was 80.3%.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

FTNT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fortinet, Inc. reported an operating income of 580.00M and revenue of 1.85B, resulting in an operating margin of 31.4%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

FTNT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fortinet, Inc. reported a net income of 534.50M and revenue of 1.85B, resulting in a net margin of 28.9%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.


Frequently Asked Questions


FTNT and UTHR have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FTNT has higher volatility (13.35%) compared to UTHR (5.01%). In terms of maximum drawdown, FTNT dropped -51.20% vs UTHR's -93.18%.

UTHR currently has the higher Sharpe Ratio (1.92 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTNT and UTHR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer